X-74591624-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000332687.11(RLIM):āc.1691A>Gā(p.Asn564Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,210,326 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000332687.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RLIM | NM_016120.4 | c.1691A>G | p.Asn564Ser | missense_variant | 4/4 | ENST00000332687.11 | NP_057204.2 | |
RLIM | NM_183353.3 | c.1691A>G | p.Asn564Ser | missense_variant | 5/5 | NP_899196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RLIM | ENST00000332687.11 | c.1691A>G | p.Asn564Ser | missense_variant | 4/4 | 1 | NM_016120.4 | ENSP00000328059 | P1 | |
RLIM | ENST00000349225.2 | c.1691A>G | p.Asn564Ser | missense_variant | 5/5 | 2 | ENSP00000253571 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000803 AC: 9AN: 112116Hom.: 0 Cov.: 24 AF XY: 0.0000584 AC XY: 2AN XY: 34264
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 183405Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67875
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1098158Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363518
GnomAD4 genome AF: 0.0000802 AC: 9AN: 112168Hom.: 0 Cov.: 24 AF XY: 0.0000583 AC XY: 2AN XY: 34326
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.1691A>G (p.N564S) alteration is located in exon 5 (coding exon 3) of the RLIM gene. This alteration results from a A to G substitution at nucleotide position 1691, causing the asparagine (N) at amino acid position 564 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at